Subscribe to our newsletter!
Follow the latest news from CATALIS and Clinical Trials Quebec
Home
The organizations listed in this Directory have registered voluntarily. This Directory is not exhaustive and does not represent all organizations providing biotechnology services in Quebec.
If you would like to include your organization, please complete this form. If you would to update your organization's information, please contact us.
We accelerate RNA-based therapy development. Nanofacile, a Montreal-based biotech startup, develops innovative RNA encapsulation solutions. Leveraging leading innovation hubs, the company aims to make RNA research and therapies more accessible and effective.
CRO services supporting grants, financial/budget structures, startup implementation, strategic planning, partnerships & alliances, annual reporting, regulatory affairs, preclinical/clinical studies – customized boutique services.
A multinational quality and compliance services group for life sciences companies, specializing in data integrity, digital governance, engineering and qualification, quality and compliance, regulatory affairs, lab excellence, pharmacovigilance, audits, and training.
RAN BioLinks Canada Ltd is a Canadian biotechnology research accelerator based in Ontario that develops AI-enabled platforms to advance clinical research and clinical trials. Through its MAESTRO suite and supporting frameworks, the company streamlines trial operations, maintains inspection-ready eTMF/CTMS and quality records, and delivers real-time analytics—enabling sponsors, sites, and research teams to run efficient, compliant, and data-driven studies with improved reliability and reproducibility.
CRO/CDMO providing development and bioproduction services for biological tools and raw materials required in cell therapy, gene therapy, immunotherapy programs, and other projects needing plasmid DNA, monoclonal antibodies, or recombinant proteins. RD-Biotech is a French biotech with over 20 years of expertise.
A pharmaceutical company providing CDMO, CMO, and bioanalytical services, including TK/PK reporting.
Seriant, a division of the Montreal Heart Institute, is a clinical research organization that provides comprehensive services to the pharmaceutical, medical device, and biotechnology industries, as well as to the academic community. Based in Montreal, Seriant operates internationally, supporting Phase I to IV clinical trials across a wide range of therapeutic areas. With our proven expertise in the development of innovative therapies, we help make a meaningful impact on people’s lives around the world.
Scimega is a Canadian clinical research organization specializing in oncology, conducting cutting-edge oncology trials for medium and small biotech companies globally. With expertise in collaboration with suppliers, Scimega ensures fast site start-up and optimal patient recruitment without compromising data quality. Its operational design is robust enough to adapt to evolving clinical trial environments.
We provide advanced services in GMP/GCP analyses, formulation R&D, clinical manufacturing, and clinical research for pharmaceutical, biopharmaceutical, and medical device sectors. Our solutions cover biologics and small molecules throughout the full lifecycle: development, testing, regulatory support, safety studies, clinical development, commercial QC, and post-market testing.
Sorintellis leverages explainable AI to optimize drug development, providing actionable insights for better, more confident decision-making. Sorintellis solutions target clinical trial risk management and pharmaceutical portfolio management, serving CROs, pharma/biotech companies, and life sciences investment funds.
PharmaLube develops LubriumMC, a high-performance lubricating biomaterial with potential applications in osteoarthritis treatment, dry eye, and other therapeutic, cosmetic, and industrial uses.
THEO Medical is an innovative player in pharmaceutical clinical research and the collection of blood products for research. We specialize in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies.
We accelerate RNA-based therapy development. Nanofacile, a Montreal-based biotech startup, develops innovative RNA encapsulation solutions. Leveraging leading innovation hubs, the company aims to make RNA research and therapies more accessible and effective.
Concordia University, McGill University
CRO services supporting grants, financial/budget structures, startup implementation, strategic planning, partnerships & alliances, annual reporting, regulatory affairs, preclinical/clinical studies – customized boutique services.
Academic institutions, health systems, research centers/institutes, biotechnology, medtech, biopharmaceutical, e-health, m-health
A multinational quality and compliance services group for life sciences companies, specializing in data integrity, digital governance, engineering and qualification, quality and compliance, regulatory affairs, lab excellence, pharmacovigilance, audits, and training.
International: QUINTIAN PHARMA, CQC (Glocal Quality Cannabis), Conceptio Provincial: BIOQuébec
ISO/IEC 27001:2022 Certified QMS ISO 9001
Commissioning, Qualification and Validation (CQV), Digital Governance, Audits
RAN BioLinks Canada Ltd is a Canadian biotechnology research accelerator based in Ontario that develops AI-enabled platforms to advance clinical research and clinical trials. Through its MAESTRO suite and supporting frameworks, the company streamlines trial operations, maintains inspection-ready eTMF/CTMS and quality records, and delivers real-time analytics—enabling sponsors, sites, and research teams to run efficient, compliant, and data-driven studies with improved reliability and reproducibility.
RAN BioLinks Canada Ltd collaborates with key stakeholders across the clinical research ecosystem to advance efficient and data-driven studies. Notable partnerships include: - Government & Public Health Bodies: Collaboration with Public Health Ontario to support data-driven research initiatives and public health programs - National Clinical Trial Initiatives: Partnership with Accelerating Clinical Trials (ACT) Consortium to contribute to the advancement and modernization of clinical trials across Canada - Academic and Research Institutions – Enabling multi-site studies and fostering innovation in clinical research CROs and SMOs: Supporting efficient trial execution, operational oversight, and real-world data integration
RAN BioLinks delivers the MAESTRO clinical research suite on a validated, GxP‑aligned compliant cloud that supports 21 CFR Part 11, EU Annex 11, GDPR, and HIPAA, keeping clinical trial data secure, traceable, and inspection‑ready.
AI‑enabled CTMS/eTMF/QMS platform, clinical trial operations optimization, inspection‑ready GxP‑aligned documentation, compliant cloud, clinical inventory and biospecimen tracking, real‑time analytics for research
CRO/CDMO providing development and bioproduction services for biological tools and raw materials required in cell therapy, gene therapy, immunotherapy programs, and other projects needing plasmid DNA, monoclonal antibodies, or recombinant proteins. RD-Biotech is a French biotech with over 20 years of expertise.
ISO 9001
Engineering and production services for plasmid DNA (Research Grade to GMP), antibodies and recombinant proteins, raw materials within R&D programs up to clinical phases (DNA): RNA therapies, DNA therapies, viral vectors, CAR-T cells. Bioproduction, plasmid DNA, recombinant antibodies, CRO, CDMO
A pharmaceutical company providing CDMO, CMO, and bioanalytical services, including TK/PK reporting.
Support for drug discovery as well as preclinical and clinical development for over 50 biotechnology companies.
GLP, GCP, GMP SCC certified, FDA audited
Bioanalysis and TK/PK reports audited by the FDA and compliant with ICH M10 standards
Seriant, a division of the Montreal Heart Institute, is a clinical research organization that provides comprehensive services to the pharmaceutical, medical device, and biotechnology industries, as well as to the academic community. Based in Montreal, Seriant operates internationally, supporting Phase I to IV clinical trials across a wide range of therapeutic areas. With our proven expertise in the development of innovative therapies, we help make a meaningful impact on people’s lives around the world.
Several international partners.
Scimega is a Canadian clinical research organization specializing in oncology, conducting cutting-edge oncology trials for medium and small biotech companies globally. With expertise in collaboration with suppliers, Scimega ensures fast site start-up and optimal patient recruitment without compromising data quality. Its operational design is robust enough to adapt to evolving clinical trial environments.
The LEAN Six Sigma Company, McPeak Sirois, SPharm
Site selection and accelerated study start-up; provincial ethics approval strategy; Health Canada regulatory strategy; country monitoring; audit and GCP compliance consulting; full range of Scimega360 services
We provide advanced services in GMP/GCP analyses, formulation R&D, clinical manufacturing, and clinical research for pharmaceutical, biopharmaceutical, and medical device sectors. Our solutions cover biologics and small molecules throughout the full lifecycle: development, testing, regulatory support, safety studies, clinical development, commercial QC, and post-market testing.
PSD, LSO, BIOQuébec, PDA
GMP, GLP, ISO 17025
Sorintellis leverages explainable AI to optimize drug development, providing actionable insights for better, more confident decision-making. Sorintellis solutions target clinical trial risk management and pharmaceutical portfolio management, serving CROs, pharma/biotech companies, and life sciences investment funds.
The Sorintellis platform allows users to input various data and generate accurate forecasts on clinical trial success probability. A priori forecasting of trial performance can help sponsors avoid failures or delays due to preventable events. Additionally, explainable machine learning used by the platform anticipates future events and enables appropriate corrective actions to mitigate risks during clinical trial planning and execution. Our solutions are targeted to Contract Research Organizations (CROs), pharmaceutical and biotech companies, and life sciences investment funds.
PharmaLube develops LubriumMC, a high-performance lubricating biomaterial with potential applications in osteoarthritis treatment, dry eye, and other therapeutic, cosmetic, and industrial uses.
THEO Medical is an innovative player in pharmaceutical clinical research and the collection of blood products for research. We specialize in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies.
Collection of blood products (blood, serum, plasma, cells)
Follow the latest news from CATALIS and Clinical Trials Quebec